Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR T cell therapy.
Shi J, Zhang Z, Chen HY, Yao Y, Ke S, Yu K, Shi J, Xiao X, He C, Xiang B, Sun Y, Gao M, Xing X, Yu H, Wang X, Yuan WC, Budiarto BR, Chen SY, Zhang T, Lee YR, Zhu H, Zhang J.
Shi J, et al. Among authors: he c.
Mol Ther. 2025 Feb 3:S1525-0016(25)00086-3. doi: 10.1016/j.ymthe.2025.01.047. Online ahead of print.
Mol Ther. 2025.
PMID: 39905727